Clinical Study

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Table 4

Comparison of hormone levels and the indices of ovarian function between the three groups.

Group 1Group 2Group 3
ObeseLean PCOSObese PCOS
nnn

Testosterone (nmol/L)53 85 67
Estradiol (pmol/L)37 62 40
Androstendione (nmol/L)17 48 33
DHEAS (mcmol/L)24 60 54
17-OH-progesteron (nmol/L)16 37 38
LH (U/L)42 74 59
FSH (U/L)42 76 60
Prolactin (U/L)47 54 49
Cortisol 8 : 00 o’clock (nmol/L)52 30 41
Cortisol 22:00 o’clock (nmol/L)44 15 29
TSH (U/L)62 39 45
Presence of polycystic ovaries (PCO) (%)31 85 62
Right ovary PCO (%)29 74 56
Left ovary PCO (%)29 77 56
Right ovary volume (mL)18 54 37
Left ovary volume (mL)20 54 35
Age of menarche (years)87 86 69
Length of menstrual cycle (days)44 56 30
Duration of menstrual bleeding (days)33 44 22
Rate of menstrual disturbances (%)107 92 79
Regular menstrual cycle (%)106 93 80
Oligiomenorrhea (%)104 93 80
Hypermenorrhea (%)103 91 80
Polymenorrhea (%)103 92 0% 80
Opsomenorrhea (%)103 92 80
Amenorrhea (%)103 92 80
Pregnancies98 87 81
Births97 87 81
Miscarriages89 86 78
Rate of infertility (%)40 20 28

## ; ### between group 1 and group 3.
* ; ** ; *** between group 2 and group 3.
; ∧∧ ; ∧∧ between group 1 and group 2.
n = number of patients.